Intrinsiqq
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics Insider Trading

MLTX

Compare
Last 12 months

Insiders sold $83M and bought nothing on the open market.

14% of the selling was scheduled in advance under 10b5-1 plans. Director Mark N Lampert sold $63M on Mar 31, 78% of their stake, outside a plan. The last open-market buy by an executive or director was in Oct 2025.

Net open-market
−$83M
0 buys · 16 sales
Under a 10b5-1 plan
14%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
Oct 2025
Oct 8, 2025

Get an email when MLTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 2710b5-1 plan
    Kristian Reich
    Chief Scientific Officer · sold 1,100 at $20.00
    22K
    <0.1% of stake
  • Jul 21 – 2210b5-1 plan
    Kristian Reich
    Chief Scientific Officer · sold 52,448 at avg $20.02
    $1.05M
    1.9% of stake
  • Jul 2010b5-1 plan
    Kristian Reich
    Chief Scientific Officer · sold 43,700 at $20.09
    878K
    1.5% of stake
  • Jul 1510b5-1 plan
    Kristian Reich
    Chief Scientific Officer · sold 16,105 at $20.01
    322K
    0.6% of stake
  • Jul 9 – 1010b5-1 plan
    Da Silva Jorge Santos
    Chief Executive Officer · sold 102,225 at avg $20.02
    $2.05M
    3.6% of stake
  • Jul 110b5-1 plan
    Da Silva Jorge Santos
    Chief Executive Officer · sold 47,775 at $20.03
    957K
    1.6% of stake
  • Jun 2210b5-1 plan
    Matthias Bodenstedt
    Chief Financial Officer · sold 39,120 at $22.04
    862K
    3.4% of stake
  • Jun 17 – 1810b5-1 plan
    Matthias Bodenstedt
    Chief Financial Officer · sold 17,876 at avg $19.67
    352K
    1.5% of stake
  • Jun 15 – 1710b5-1 plan
    Kristian Reich
    Chief Scientific Officer · sold 150,000 at avg $19.01
    $2.85M
    5.0% of stake
  • May 1110b5-1 plan
    Matthias Bodenstedt
    Chief Financial Officer · sold 13,653 at $20.02
    273K
    1.2% of stake
  • Apr 1410b5-1 plan
    Matthias Bodenstedt
    Chief Financial Officer · sold 2,426 at $19.56
    47K
    0.2% of stake
  • Apr 10 – 13No plan
    Da Silva Jorge Santos
    Chief Executive Officer · sold 150,000 at avg $18.35
    $2.75M
    4.9% of stake
  • Apr 9 – 1010b5-1 plan
    Matthias Bodenstedt
    Chief Financial Officer · sold 87,795 at avg $18.95
    $1.66M
    6.9% of stake
  • Mar 31No plan
    Mark N Lampert
    Director · sold 3,750,000 at avg $16.79
    $63M
    78% of stake
  • Dec 8, 2025 – Dec 9, 2025No plan
    Da Silva Jorge Santos
    Chief Executive Officer · sold 200,000 at avg $14.87
    $2.97M
    6.5% of stake
  • Dec 8, 2025 – Dec 9, 2025No plan
    Kristian Reich
    Chief Scientific Officer · sold 202,908 at avg $14.85
    $3.01M
    6.4% of stake
  • Oct 8, 2025
    Matthias Bodenstedt
    Chief Financial Officer · bought 10,870 at $9.09
    99K
    1.8% of stake
  • Sep 29, 2025 – Sep 30, 2025No plan
    Cormorant Global Healthcare Master Fund, LP
    Large holder · sold 6,499,978 at avg $7.21
    $46.9M
    77% of stake
  • Jul 3, 2025No plan
    Catherine Moukheibir
    Director · sold 23,500 at $48.79
    $1.15M
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MLTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MLTX

CompareIntrinsic value
OPKOpko Health Inc.
$1.57-2.48%28
INVAInnoviva Inc.
$18.41+0.00%60
PAHCPhibro Animal Health Corporation
$33.29-2.32%57
NUVBNuvation Bio Inc.
$3.80-0.26%10
RAREUltragenyx Pharmaceutical Inc.
$16.48-4.30%40
PRGOPerrigo Company plc
$15.94-0.62%17
RCUSArcus Biosciences Inc.
$15.62-1.01%10
XNCRXencor Inc.
$33.26-2.21%11

Held by ETFs

MLTX is in 14 US ETFs. The largest of them, with MLTX's weight in each:

Spot a number that looks wrong? Check it in MLTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing MLTX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.